J&J los­es at­tempt to ex­tend patent in In­dia for tu­ber­cu­lo­sis drug

In­dia’s patent of­fice de­nied John­son & John­son’s at­tempt to ex­tend the com­pa­ny’s patent on a for­mu­la­tion of be­daquiline, which is used to treat drug-re­sis­tant tu­ber­cu­lo­sis …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER